Asalyxa Bio
Pioneering a breakthrough in therapeutics by targeting over-reactive immune cells to address significant unmet medical needs across various disease conditions.
General Information
Get notified when Asalyxa Bio moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Asalyxa Bio
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Biotechnology
About Asalyxa Bio
Taxonomy: Therapeutics, Drug development, Platform technology, Immune signaling, Targeted delivery, Hyperactive immune cells, Unmet medical needs, Dysregulation, Novel therapeutics, Disease areas, Medical conditions, Innovative treatments, Immune cell targeting, Immunotherapy
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed Round | •••••• | 1 |
|
26 Jul 2021 |
| Seed Round | •••••• | 6 |
|
23 Feb 2021 |
Asalyxa Bio Alternatives & Competitors
Every immune system has a story to tell; the key is knowing how to listen.
Rebalancing Immune Function for Chronic Inflammatory and Autoimmune Diseases
ImmunoBiome aims to develop microbiome therapeutics to treat incurable diseases like cancer and auto...
FAQ About Asalyxa Bio
Don't just browse. Track.
Signal Tracker monitors Asalyxa Bio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
